Polaris Market Research recently published a research report on “Human Milk Oligosaccharides (HMO) Market Share, Size, Trends, Industry Analysis Report, By Type (2’FL, 3’FL, 3’SL, 6’SL), By Application; By Distribution Channel; By Region; Segment Forecast, 2022 – 2030” in its research database.
According to the research report, the global human milk oligosaccharides (HMO) market share was valued at USD 189.66 million in 2021 and is expected to reach over USD 1,003.07 Million By 2030, growing at a CAGR of 22.4% during the forecast period.
What are Human Milk Oligosaccharides (HMO)? How Big is Human Milk Oligosaccharides (HMO) Market Size & Share?
Human Milk Oligosaccharides (HMO) are the third most common constituent of human milk after lactose and lipids. Human Milk Oligosaccharides (HMO) boost your baby’s immune system. They also protect infants from the risk of pathogen infections and enhance brain development and cognition. There are more than 100 different forms of HMOs. However, 2′-FL HMO is the most common HMO found in a mother’s breast milk. They can also protect babies against causative organisms, such as protozoan parasites, pathogenic bacteria, viruses, and fungi.
Commercially available HMO prebiotics are formed chemically through fermentation or enzymatic synthesis. There is a high demand for the biosynthetic production of HMOs as they provide functional benefits to infants when added to additives in infant formulas and other dietary products. Increasing developments in research and development activities in Human Milk Oligosaccharides (HMO) products is one of the prominent factors driving the growth of the market.
Request Sample Copy of Human Milk Oligosaccharides (HMO) Market Research Report @ https://www.polarismarketresearch.com/industry-analysis/human-milk-oligosaccharides-hmo-market/request-for-sample
(The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, a Table of Contents, a Graphical introduction of regional analysis, Top players in the market with their revenue analysis, and our research methodology.)
Some of the Top Market Players Covered Are:
- Abbott Laboratories
- BASF S.E.
- Biosynth Carbosynth
- Hansen Holding A/S
- Dextra Laboratories Ltd.
- Dupont Nutrition & Biosciences
- Elicityl S.A.
- Glycom A/S
- Inbiose NV
- Medolac Laboratories
- Neolacta Lifesciences Pvt. Ltd
- Nestle Health Science
- Royal DSM
- Royal FrieslandCampina N.V.
Directly Purchase a copy of the report with TOC @ https://www.polarismarketresearch.com/checkouts/14951
Key Growth Drivers:
The growing application of HMOs in functional foods coupled with increasing demand for infant formula fuels the growth of the HMOs market. The rise in awareness about health consciousness among the population and changing diets and lifestyles have led consumers to move towards functional foods, such as dietary supplements and probiotics. These factors are propelling the demand for Human Milk Oligosaccharides (HMO). Other Human Milk Oligosaccharides (HMO) market trends that positively influence the market’s growth include the increasing developments of new technologies, including enzymatic trans-glycosylation.
Moreover, the surge in demand for oligosaccharides applications in infant formula is expected to accelerate the market sales of Human Milk Oligosaccharides (HMO). The rapid development of the dairy industry is another important factor expected to contribute to the significant revenue growth of the market. HMOs in food supplements and other products help treat specific disorders and prevent the risk of other health diseases, which is expected to create opportunities in the Human Milk Oligosaccharides (HMO) industry.
Inquire more about this report before purchase @ https://www.polarismarketresearch.com/industry-analysis/human-milk-oligosaccharides-hmo-market/inquire-before-buying
(Inquire a report quote OR available discount offers to the sales team before purchase.)
The Research Report Segmented Based on:
- Insight by Type
The 2’FL segment is expected to dominate the market
Based on product type, the human milk oligosaccharides (HMOs) market is segmented into 2’FL, 3’FL, 3’SL, and 6’SL. The 2’FL segment accounted for the largest share in 2021 and is anticipated to continue its dominance in the Human Milk Oligosaccharides (HMO) market over the forecast period. 2′-fucosyllactose (2’FL) is known as the most prevalent human milk oligosaccharide (HMO) naturally found in human breast milk. It protects infants against infectious diseases.
- Insight by Application
Infant formula is expected to achieve the largest market share.
Based on application, infant formula led the market with the largest share in Human Milk Oligosaccharides (HMO) market in 2021 and is expected to dominate the market over the forecast period. This growth can be attributed to the rise in demand for HMOs in designing infant formulas due to the beneficial and functional properties of HMOs. Also, these HMO products prevent infants from the risk of infection and their prebiotic effects as well as nourish brain development and gut health maintenance.
Request for Discount on this Report Before Purchase @ https://www.polarismarketresearch.com/industry-analysis/human-milk-oligosaccharides-hmo-market/request-for-discount-pricing
Human Milk Oligosaccharides (HMO) Market: Report Scope
|Market Outlook for 2030||USD 1,003.07 Million|
|Market Size 2021 Value||USD 189.66 Million|
|Expected CAGR Growth||22.4% from 2022 – 2030|
|Forecast Year||2022 – 2030|
|Top Market Players||Abbott Laboratories, BASF S.E., Biosynth Carbosynth, Chr. Hansen Holding A/S, Dextra Laboratories Ltd., Dupont Nutrition & Biosciences, Elicityl S.A., Glycom A/S, Glycosyn, Inbiose NV, Medolac Laboratories, Neolacta Lifesciences Pvt. Ltd, Nestle Health Science, Royal DSM, Royal FrieslandCampina N.V., and ZuChem.|
|Segments Covered||By Type, By Application, By Distribution Channel, By Region|
|Customization Options||Customized purchase options are available to meet your research needs. Explore customized purchase options|
Asia Pacific will achieve significant growth in the Human Milk Oligosaccharides (HMO) market
On the basis of geography, Asia Pacific is anticipated to gather significant growth in the Human Milk Oligosaccharides (HMO) industry. There is a huge consumer base available in various countries in the Asia Pacific region, such as China, Japan, India, and others. Therefore, these nations are expected to adopt HMOs immensely. Also, the increasing population in emerging countries like China and India is fueling the infant formula market, where HMO is used as a vital content for developing infant foods and other supplements.
Moreover, a surge in demand for infant formula is anticipated to create lucrative opportunities in Human Milk Oligosaccharides (HMO) market in China during the anticipated period. Also, factors such as rising disposable income, mortality rate, and awareness about health and hygiene consciousness are expected to promote the market’s growth in the region.
Browse the Detail Report “Human Milk Oligosaccharides (HMO) Market Share, Size, Trends, Industry Analysis Report, By Type (2’FL, 3’FL, 3’SL, 6’SL), By Application; By Distribution Channel; By Region; Segment Forecast, 2022 – 2030” with in-depth TOC: https://www.polarismarketresearch.com/industry-analysis/human-milk-oligosaccharides-hmo-market
For Additional Information OR Media Enquiry, Please Mail Us At: firstname.lastname@example.org
- In June 2021, H&H Group, Australia, launched its first kid’s supplement that consists of Human Milk Oligosaccharides (HMOs). The product, named ProBOOST + VIT D, was launched by the brand Biostime and is suitable for kids aged 12 months and above.
- In April 2020, Kyowa Hakko, an international health ingredient manufacturer, established a new facility to produce human milk oligosaccharides (HMOs) in Thailand due to the increasing demand worldwide for these health products in the coming years.
Polaris Market Research has segmented the Human Milk Oligosaccharides (HMO) market report based on type, application, distribution channel, and region:
Human Milk Oligosaccharides (HMO) Market: By Type Outlook
Human Milk Oligosaccharides (HMO) Market: By Application Outlook
- Infant Formula
- Functional Food & Beverage
- Food Supplements
Human Milk Oligosaccharides (HMO) Market: By Distribution channel Outlook
- Hypermarkets & Supermarkets
- Drug Store or Pharmacy
- Mass Merchandiser, Departmental Stores
- Mono-brand Stores
- Specialty Stores
- Online Sales Channel
Human Milk Oligosaccharides (HMO) Market: By Region Outlook
- North America (U.S., Canada)
- Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
- Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
- Latin America (Brazil, Mexico, Argentina)
- Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.
30 Wall Street
New York City, NY 10005,
Phone: +1-929 297-9727